Rytary in clinical trials Approvals of Rytary were mainly supported by positive data from two Phase 3 studies: APEX-PD (NCT00880620) and ADVANCE-PD (NCT00974974)
Pasteurized Akkermansia muciniphila increases whole-body energy expenditure and fecal energy excretion in diet-induced obese mice
doi:10.1053/j.gastro.2003.09.035
Excessive ROS disrupt the oxidation-antioxidant balance, activate inflammatory cell signals, and induce endothelial cell dysfunction through mitochondria-mediated apoptosis, promoting vascular smooth muscle cell proliferation, interfering with nitric oxide synthesis, and delaying endothelial repair, thereby accelerating atherosclerosis development (Tullio et al., 2013
albicans filamentation, modulation of the fungal cell wall, and reduce fungal adhesion to cell host
Its the foundation everything else is built on